Photodynamic therapy (PDT) uses exogenously administered or endogenous
ly formed photosensitizers activated by light to induce cell death via
formation of singlet oxygen and other free radicals. Photodynamic the
rapy is increasingly used for the treatment of skin cancers and other
indications. The efficacy of PDT depends on the structure of the photo
sensitizer, the administration modality, the light source, and the tre
atment procedure. We reviewed the most recent clinical and experimenta
l developments in PDT research related to dermatology. The substrate u
nder most intense investigation in PDT research is delta-aminolevulini
c acid (ALA). Photodynamic therapy with topically applied ALA has been
shown to be highly efficient in the treatment of cutaneous neoplasms
by using intralesionally formed porphyrins as photosensitizers. For so
lar keratoses, best response rates have been described. delta-Aminolev
ulinic-PDT is also efficient in the treatment of superficial basal cel
l and squamous cell carcinomas. In addition, the fluorescence of ALA-i
nduced porphyrins under a Wood light is highly selective in neoplastic
cutaneous tissue and offers a useful technique in detecting and delin
eating skin tumors with ill-defined borders.